{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:22:39Z","timestamp":1787703759202,"version":"build-2784847793"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":70,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006390","name":"University of Lausanne","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006390","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Acquired von Willebrand syndrome is a rare and often underdiagnosed entity, secondary to different pathologies, often of autoimmune or paraneoplastic etiology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>Here, we report the first case of acquired von Willebrand syndrome secondary to rectal adenocarcinoma in a 62-year-old white patient with a negative history of a hemorrhagic diathesis. The patient received chemo-radiotherapy with tumor mass decrease and subsequent surgical removal. A pre-surgery workup identified isolated prolonged aPTT that led to coagulation factor analysis. Following prophylactic von Willebrand factor substitution, the surgery was performed without hemorrhagic complications. After treatment of the oncological disease, we observed spontaneous resolution of von Willebrand syndrome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>It is important to recognize acquired von Willebrand syndrome because it can put the patient at a high risk of bleeding complications. Our case reports, for the first time, the presence of this syndrome secondary related to rectal adenocarcinoma. We also reviewed a few cases of acquired von Willebrand syndrome secondary to underlying solid tumors described in the literature.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13256-026-06234-1","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T04:14:03Z","timestamp":1781669643000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Acquired von Willebrand syndrome in a patient with rectal adenocarcinoma: a case report and review of the literature"],"prefix":"10.1186","volume":"20","author":[{"given":"Stefano","family":"De Polo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariangela","family":"Costanza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Grandoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Alberio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerasimos","family":"Tsilimidos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"6234_CR1","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.3324\/haematol.2020.255117","volume":"105","author":"M Franchini","year":"2020","unstructured":"Franchini M, Mannucci PM. Acquired von Willebrand syndrome: focused for hematologists. Haematologica. 2020;105:2032\u20137.","journal-title":"Haematologica"},{"key":"6234_CR2","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1055\/s-0037-1614018","volume":"84","author":"AB Federici","year":"2000","unstructured":"Federici AB, et al. Acquired von Willebrand syndrome: data from an international registry. Thromb Haemost. 2000;84:345\u20139.","journal-title":"Thromb Haemost"},{"key":"6234_CR3","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/j.1528-1157.1992.tb02303.x","volume":"33","author":"W Kreuz","year":"1992","unstructured":"Kreuz W, et al. Valproate therapy induces von Willebrand disease type I. Epilepsia. 1992;33:178\u201384.","journal-title":"Epilepsia"},{"key":"6234_CR4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/ajh.2830490114","volume":"49","author":"G Castaman","year":"1995","unstructured":"Castaman G, Lattuada A, Mannucci PM, Rodeghiero F. Characterization of two cases of acquired transitory von willebrand syndrome with ciprofloxacin: evidence for heightened proteolysis of von willebrand factor. Am J Hematol. 1995;49:83\u20136.","journal-title":"Am J Hematol"},{"key":"6234_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26246","volume":"64","author":"E Fosbury","year":"2017","unstructured":"Fosbury E, Szychot E, Slater O, Mathias M, Sibson K. An 11\u2010year experience of acquired von Willebrand syndrome in children diagnosed with Wilms tumour in a tertiary referral centre. Pediatr Blood Cancer. 2017;64: e26246.","journal-title":"Pediatr Blood Cancer"},{"key":"6234_CR6","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1089\/cren.2018.0032","volume":"4","author":"B Odom","year":"2018","unstructured":"Odom B, Khourdaji I, Golas V, Zekman R, Rosenberg B. Acquired von Willebrand disease secondary to clear cell renal cell carcinoma. J Endourol Case Rep. 2018;4:114\u20136.","journal-title":"J Endourol Case Rep"},{"key":"6234_CR7","first-page":"622","volume":"33","author":"AK Agrawal","year":"2011","unstructured":"Agrawal AK, Golden C, Matsunaga A. Acquired von Willebrand disease in an osteosarcoma patient. J Pediatr Hematol Oncol. 2011;33:622\u20133.","journal-title":"J Pediatr Hematol Oncol"},{"key":"6234_CR8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/08880010500457749","volume":"23","author":"M Elli","year":"2006","unstructured":"Elli M, et al. Acquired von willebrand syndrome in a patient with Ewing sarcoma. Pediatr Hematol Oncol. 2006;23:111\u20134.","journal-title":"Pediatr Hematol Oncol"},{"key":"6234_CR9","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/mpo.2950250213","volume":"25","author":"U Nowak-G\u00f6ttl","year":"1995","unstructured":"Nowak-G\u00f6ttl U, et al. Acquired von willebrand disease in malignant peripheral neuroectodermal tumor (PNET). Med Pediatr Oncol. 1995;25:117\u20138.","journal-title":"Med Pediatr Oncol"},{"key":"6234_CR10","doi-asserted-by":"publisher","first-page":"e95","DOI":"10.1016\/j.clgc.2015.07.013","volume":"14","author":"G Dumas","year":"2016","unstructured":"Dumas G, Rousseau B, Rodrigues MJ, Tlemsani C, Goldwasser F. Acquired Type II von Willebrand Syndrome in Locally Advanced Bladder Cancer Successfully Treated With Intravenous Immunoglobulin and Chemotherapy. Clin Genitourin Cancer. 2016;14:e95\u20137.","journal-title":"Clin Genitourin Cancer"},{"key":"6234_CR11","doi-asserted-by":"crossref","unstructured":"Chilvers, G. S. & Porter, G. Acquired von Willebrand\u2019s disease associated with epithelial myoepithelial carcinoma of the parotid salivary gland. Case Rep. 2014, bcr2014205248\u2013bcr2014205248 (2014).","DOI":"10.1136\/bcr-2014-205248"},{"key":"6234_CR12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1055\/s-0036-1592167","volume":"43","author":"P-E Claus","year":"2016","unstructured":"Claus P-E, Van Haute I, Verhoye E, Deeren D, Moreau E. Diagnostic challenges in acquired von Willebrand syndrome: a complex case of prostate carcinoma associated-acquired von Willebrand syndrome. Semin Thromb Hemost. 2016;43:101\u20134.","journal-title":"Semin Thromb Hemost"},{"key":"6234_CR13","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1111\/j.1365-2141.1992.tb04562.x","volume":"80","author":"T Facon","year":"1992","unstructured":"Facon T, et al. Acquired type II von Willebrand\u2019s disease associated with adrenal cortical carcinoma. Br J Haematol. 1992;80:488\u201394.","journal-title":"Br J Haematol"},{"key":"6234_CR14","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1182\/blood.V64.3.614.614","volume":"64","author":"PM Mannucci","year":"1984","unstructured":"Mannucci PM, et al. Studies of the pathophysiology of acquired von Willebrand\u2019s disease in seven patients with lymphoproliferative disorders or benign monoclonal gammopathies. Blood. 1984;64:614\u201321.","journal-title":"Blood"},{"key":"6234_CR15","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s00134-011-2370-6","volume":"38","author":"C Heilmann","year":"2012","unstructured":"Heilmann C, et al. Acquired von Willebrand syndrome in patients with extracorporeal life support (ECLS). Intensive Care Med. 2012;38:62\u20138.","journal-title":"Intensive Care Med"},{"key":"6234_CR16","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1213\/ANE.0000000000000554","volume":"120","author":"H Tauber","year":"2015","unstructured":"Tauber H, et al. Extracorporeal membrane oxygenation induces short-term loss of high-molecular-weight von Willebrand factor multimers. Anesth Analg. 2015;120:730\u20136.","journal-title":"Anesth Analg"},{"key":"6234_CR17","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/S0140-6736(87)92272-0","volume":"1","author":"RG Dalton","year":"1987","unstructured":"Dalton RG, et al. Hypothyroidism as a cause of acquired von Willebrand\u2019s disease. Lancet Lond Engl. 1987;1:1007\u20139.","journal-title":"Lancet Lond Engl"},{"key":"6234_CR18","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/ajh.2830350210","volume":"35","author":"C Richard","year":"1990","unstructured":"Richard C, et al. Acquired von Willebrand disease in multiple myeloma secondary to absorption of von Willebrand factor by plasma cells. Am J Hematol. 1990;35:114\u20137.","journal-title":"Am J Hematol"},{"key":"6234_CR19","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1177\/107602960100700204","volume":"7","author":"JJ Michiels","year":"2001","unstructured":"Michiels JJ, Schroyens W, Bememan Z, van der Planken M. Atypical variant of acquired von willebrand syndrome in wilms tumor: is hyaluronic acid secreted by nephroblastoma cells the cause? Clin Appl Thromb. 2001;7:102\u20135.","journal-title":"Clin Appl Thromb"},{"key":"6234_CR20","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/ajh.2830240304","volume":"24","author":"AW Bracey","year":"1987","unstructured":"Bracey AW, et al. Platelet dysfunction associated with wilms tumor and hyaluronic acid. Am J Hematol. 1987;24:247\u201357.","journal-title":"Am J Hematol"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-026-06234-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-026-06234-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-026-06234-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T23:40:10Z","timestamp":1787701210000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13256-026-06234-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6234"],"URL":"https:\/\/doi.org\/10.1186\/s13256-026-06234-1","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"11 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was not required for this single case report, in accordance with the institutional\/national policy.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","label":"Consent of publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"497"}}